Australia Becomes First Country to Classify Psychedelics as Medicines, Despite Caution from Health O

In a ground-breaking decision earlier this year, Australia's conservative medicines regulator approved the use of psychedelics for therapy sessions. The move allows for the benefit of psilocybin, found in magic mushrooms, to treat treatment-resistant depression, and MDMA (ecstasy) for post-traumatic stress disorder (PTSD).

Effective from 1st July 2023 Saturday, this classification makes Australia the first country to recognize psychedelics as medicines nationally. While hailed as a landmark moment by experts and patients, major health organizations have expressed caution.

Concerns include the need for larger-scale studies, potential risks, long-term side effects, and the possibility of limited benefits. The debate continues as Australia pioneers this new frontier in therapy.